Thank you, Thomas. And good morning, everyone. Turning to our financial results. For the second quarter we reported revenue of $266,000 from hybrid system sales, compared to $172,000 in the second quarter of a year ago. Operating expenses totaled $38.5 million, an increase of $6.3 million compared to the second quarter of last year. The year-over-year increase in spending is due to growth and research and development costs partly offset by lower SG&A expenses. R&D costs were up $7.4 million in the quarter due to higher expenses related to Hypertruck ERX powertrain development and KARNO. Powertrain development costs went up $3.7 million as we expense production truck components that were received in the quarter. I mentioned last quarter that until we complete R&D work on the Hypertruck ERX system, all component purchases will continue to be expensed even if those parts will ultimately be used in production power trains that are later sold to customers. The impact of this expensing was partly offset by lower expenses related to other R&D work on the Hypertruck ERX system in the quarter. Going forward, we expect that expensing of production component purchases will have a negligible impact on our R&D costs, as we make progress towards Hypertruck ERX system commercialization. The second driver of higher R&D costs in the quarter was KARNO expenses that we did not have in 2022. As a reminder, we purchased KARNO Technology from GE, late in the third quarter of 2022 and therefore, comparisons of year-over-year expenses in the first three quarters of this year need to account for this difference. Total KARNO expenses in the second quarter, were $3.7 million. In total, Hyliion reported a net loss of $35.2 million for the second quarter, which is up from the $33.5 million loss the company reported a year ago, as lower cost of sales and higher interest income this year nearly offset higher operating expenses. Looking at year-to-date performance for the first half of the year, revenue was $576,000, compared to $512,000 in 2022. Total operating expenses were $70.4 million, compared to $57.9 million in 2022. Again, the increase in expenses was driven by higher R&D expenses of $12.5 million, of which $5.4 million consisted of the expensing of production component purchases, partly offset by lower costs for other powertrain R&D work. The remaining $7.1 million of higher year-over-year R&D cost was driven by KARNO expenses in the first half. Finally, SG&A expenses in the first half were approximately flat with 2022. Our net loss year-to-date was $64.1 million, compared to $60.6 million in the first half of 2022. We ended the quarter with total cash, short term and long-term investments of $354 million, compared to $422 million at the end of 2022 and $385 million at the end of the first quarter of this year. We spent $31 million in the second quarter, compared to $37 million in the first quarter and $27 million in the second quarter of 2022. As we discussed last quarter, we are taking actions that will help reduce cash burn and expect that these actions will significantly reduce operating expenses, capital spending and working capital growth. We continue to hold to the guidance that we shared at our Investor Day back in June of approximately $130 million total operating expenses, despite the unexpected impact of production truck component expensing this year. Also, we continue to project cash consumption of less than $150 million, including cash operating expenses, working capital growth, and capital expenditures. As previously noted, we ended the second quarter with $354 million of total capital which gives us flexibility to continue Hypertruck ERX commercialization work, including initial truck deliveries, as well as KARNO development work. We expect to finish the year with a total capital balance of around $275 million, which will give us financial flexibility into the future. We have no plans to raise capital this year, but we'll remain opportunistic in 2024 and beyond if market conditions are favorable for raising additional equity capital. With that, I'll turn it back over to Thomas.